A carregar...
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Previously, it was found that 5‐ASA drugs in doses of at least 2 g/day, were more effective than placebo but no more effective th...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2016
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045743/ https://ncbi.nlm.nih.gov/pubmed/27101467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000543.pub4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|